ADAMTS-7, a novel proteolytic culprit in vascular remodeling

( views:198, downloads:0 )
Author:
WANG Li(Department of Physiology and Pathophysiology, Key Laboratory of Molecular Cardiovascular Science of Ministry of Education,Beijing 100191, China)
WANG Xian(Department of Physiology and Pathophysiology, Key Laboratory of Molecular Cardiovascular Science of Ministry of Education,Beijing 100191, China)
KONG Wei(Department of Physiology and Pathophysiology, Key Laboratory of Molecular Cardiovascular Science of Ministry of Education,Beijing 100191, China)
Journal Title:
ACTA PHYSIOLOGICA SINICA
Issue:
Volume 62, Issue 04, 2010
DOI:
Key Word:
ADAMTS-7;COMP;vascular smooth muscle;migration;proliferation

Abstract: Vascular remodeling is being recognized as a fundamental process during atherosclerosis and restenosis. Cumulative studies have demonstrated that extracellular matrix (ECM) degrading enzymes play a critical role during vascular remodeling. A disintegrin and metalloproteinase with thrombospondin motifs (ADAMTS) family is a recently identified metalloproteinase family which also has capacity to degrade ECM. ADAMTS family consists of 19 members and has been linked to a variety of physiological processes including development, angiogenesis, coagulation etc. Aberrant expression or function of ADAMTS members have been implicated to many disease states such as arthritis, cancer, thrombocytopenic purpura, but barely described with regard to cardiovascular disease. This review summarizes the recent advance with respect to the role of ADAMTS-7 in vascular remodeling. We review the structure, tissue distribution, substrate, expression and regulation of ADAMTS-7, especially highlight the fine tune by ADAMTS-7 of its substrate cartilage oligomeric matrix protein (COMP) in maintaining vascular homeostasis. By use of rat carotid artery balloon injury model to mimic vascular injury in vivo, we found that ADAMTS-7 protein was accumulated preferentially in neointima and mainly localized in vascular smooth muscle cells (VSMCs). Adenovirus-elicited ADAMTS-7 overexpression greatly accelerated VSMCs migration and proliferation both in vivo and in vitro, and subsequently aggravated neointima thickening post-injury. Conversely, siRNA-mediated ADAMTS-7 knock down bonafide inhibited VSMCs migration and proliferation in cultured VSMCs and injured arteries, and ultimately ameliorated neointima area. Further studies demonstrated that ADAMTS-7 facilitated VSMCs migration through degradation of its substrate COMP. Moreover, we elucidated that COMP has the capacity to maintain the contractile phenotype of VSMCs through interacting with integrin α7β1. ADAMTS-7 may therefore serve as a novel therapeutic target for atherosclerosis and postangioplasty restenosis.

  • [1]Ross R.Atherosclerosis-an inflammatory disease.N Engl J Med 1999; 340(2):115-126.
  • [2]Ye HY (叶红燕),Yin M,Shang YJ,Dai XD,Zhang SQ,Jing W,Du HQ,Zhang L,Pan J.Differential expressions of lipid metabolism related genes in the liver of young apoE knockout mice.Acta Physiol Sin (生理学报) 2008; 60(1):51-58 (Chinese,English abstract).
  • [3]Hu J,Van den Steen PE,Sang QX,Opdenakker G.Matrix metalloproteinase inhibitors as therapy for inflammatory and vascular diseases.Nat Rev Drug Discov 2007; 6(6):480-498.
  • [4]Lafont A,Durand E,Samuel JL,Besse B,Addad F,Levy BI,Desnos M,Guerot C,Bonlanger CM.Endothelial dysfunction and collagen accumulation:two independent factors for restenosis and constrictive remodeling after experimental angioplasty.Circulation 1999; 100(10):1109-1115.
  • [5]Bassiouny HS,Song RH,Hong XF,Singh A,Kocharyan H,Glagov S.How regulation of 72-kD collagenase Ⅳ (MMP-2) after experimental arterial injury.Circulation 1998; 98(2):157-163.
  • [6]Uemura S,Matsushita H,Li W,Glassford AJ,Asagami T,Lee KH,Harrison DG,Tsao PS.Diabetes mellitus enhances vascular matrix metalloproteinase activity:role of oxidative stress.Circ Res 2001; 88(12):1291-1298.
  • [7]Galis ZS,Muszynski M,Sukhova GK,Simon-Morrissey E,Unemori EN,Lark MW,Amento E,Libby P.Cytokine-stimulated human vascular smooth muscle cells synthesize a complement of enzymes required for extracellular matrix digestion.Circ Res 1994; 75(1):181-189.
  • [8]Shah PK,Falk E,Badimon J J,Fernandez-Ortiz A,Mailhac A,Villareal-Levy G,Fallon JT,Regnstrom J,Fuster V.Human monocyte-derived macrophages induce collagen breakdown in fibrous caps of atherosclerotic plaques.Potential role of matrixdegrading metalloproteinases and implications for plaque rupture.Circulation 1995; 92(6):1565-1569.
  • [9]Sluijter JP,de Kleijn DP,Pasterkamp G.Vascular remodeling and protease inhibition-bench to bedside.Cardiovasc Res 2006; 69(3):595-603.
  • [10]Newby AC.Dual role of matrix metalloproteinases (matrixins) in intimal thickening and atherosclerotic plaque rapture.Physiol Rev 2005; 85(1):1-31.
  • [11]Peterson JT.The importance of estimating the therapeutic index in the development of matrix metalloproteinase inhibitors.Cardiovasc Res 2006; 69(3):677-687.
  • [12]Galis ZS,Johnson C,Godin D,Magid R,Shipley JM,Senior RM,Ivan E.Targeted disruption of the matrix metalloproteinase9 gene impairs smooth muscle cell migration and geometrical arterial remodeling.Circ Res 2002; 91(9):852-859.
  • [13]Lijnen HR,Van Hoef B,Vanlinthout I,Verstreken M,Rio MC,Collen D.Accelerated neointima formation after vascular injury in mice with stromelysin-3 (MMP-11) gene inactivation.Arterioscler Thromb Vase Biol 1999; 19(12):2863-2870.
  • [14]Tortorella MD,Burn TC,Pratta MA,Abbaszade I,Hollis JM,Liu R,Rosenfeld SA,Copeland RA,Decicco CP,Wynn R,Rockwell A,Yang F,Duke JL,Solomon K,George H,Bruckner R,Nagase H,Itoh Y,Ellis DM,Ross H,Wiswall BH,Murphy K,Hillman MC Jr,Hollis GF,Newton RC,Magolda RL,Trzaskos JM,Arner EC.Purification and cloning of aggrecanase-1:a member of the ADAMTS family of proteins.Science 1999; 284 (5420):1664-1666.
  • [15]Tortorella MD,Pratta M,Liu RQ,Austin J,Ross OH,Abbaszade I,Burn T,Arner E.Sites of aggrecan cleavage by recombinant human aggrecanase-1 (ADAMTS-4).J Biol Chem 2000; 275 (24):18566-18573.
  • [16]Vazquez F,Hastings G,Ortega MA,Lane TF,Oikemus S,Lombardo M,Iruela-Arispe ML.METH-1,a human ortholog of ADAMTS-1,and METH-2 are members of a new family of proteins with angio-inhibitory activity.J Biol Chem 1999; 274 (33):23349-23357.
  • [17]Colige A,Sieron AL,Li SW,Schwarze U,Petty E,Wertelecki W,Wilcox W,Krakow D,Cohn DH,Reardon W,Byers PH,Lapiere CM,Prockop DJ,Nusgens BV.Human Ehlers-Danlos syndrome type Ⅶ C and bovine dermatosparaxis are caused by mutations in the procollagen I N-proteinase gene.Am J Hum Genet 1999; 65(2):308-317.
  • [18]Levy GG,Nichols WC,Lian EC,Forond T,McClintick JN,McGee BM,Yang AY,Siemieniak DR,Stark KR,Gruppo R,Sarode R,Shurin SB,Chandrasekaran V,Stabler SP,Sabio H,Bouhassira EE,Upshaw JD Jr,Ginsburg D,Tsai HM.Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura.Nature 2001; 413(6855):488-494.
  • [19]Jonsson-Rylander AC,Nilsson T,Fritsche-Danielson R,Hammarstrom A,Behrendt M,Andersson JO,Lindgren K,Andersson AK,Wallbrandt P,Rosengren B,Brodin P,Thelin A,Westin A,Hurt-Camejo E,Lee-Sogaard CH.Role of ADAMTS1 in atherosclerosis:remodeling of carotid artery,immunohistochemistry,and proteolysis of versican.Arterioscler Thromb Vasc Biol 2005; 25(1):180-185.
  • [20]Sabatine MS,Ploughman L,Simonsen KL,Iakoubova OA,Kirchgessner TG,Ranade K,Tsuchihashi Z,Zerba KE,Long DU,Tong CH,Packard CJ,Pfeffer MA,Devlin JJ,Shepherd J,Campos H,Sacks FM,Braunwald E.Association between ADAMTS1 matrix metalloproteinase gene variation,coronary heart disease,and benefit of statin therapy.Arterioscler Thromb Vasc Biol 2008; 28(3):562-567.
  • [21]Wagsater D,Bjork H,Zhu C,Bjorkegren J,Valen G,Hamsten A,Eriksson P.ADAMTS-4 and-8 are inflammatory regulated enzymes expressed in macrophage-rich areas of human atherosclerotic plaques.Atherosclerosis 2008; 196(2):514-522.
  • [22]Wang L,Zheng J,Bai X,Liu B,Liu CJ,Xu Q,Zhu Y,Wang N,Kong W,Wang X.ADAMTS-7 mediates vascular smooth muscle cell migration and neointima formation in balloon-injured rat arteries.Circ Res 2009; 104(5):688-698.
  • [23]Liu CJ,Kong W,Ilalov K,Yu S,Xu K,Prazak L,Fajardo M,Sehgal B,Di Cesare PE.ADAMTS-7:a metalloproteinase that directly binds to and degrades cartilage oligomeric matrix protein.FASEB J 2006; 20(7):988-990.
  • [24]Somerville RP,Longpre JM,Apel ED,Lewis RM,Wang LW,Sanes JR,Leduc R,Apte SS.ADAMTS7B,the full-length product of the ADAMTS7 gene,is a chondroitin sulfate proteoglycan containing a mucin domain.J Biol Chem 2004; 279(34):35159-35175.
  • [25]Oldberg A,Antonsson P,Lindblom K,Heinegard D.COMP (cartilage oligomeric matrix protein) is structurally related to the thrombospondins.J Biol Chem 1992; 267(31):22346-22350.
  • [26]Riessen R,Fenchel M,Chen H,Axel DI,Karsch KR,Lawler J.Cartilage oligomeric matrix protein (thrombospondin-5) is expressed by human vascular smooth muscle cells.Arterioscler Thromb Vasc Biol 2001; 21(1):47-54.
  • [27]Luan Y,Kong L,Howell DR,Ilalov K,Fajardo M,Bai XH,Di Cesare PE,Goldring MB,Abramson SB,Liu CJ.Inhibition of ADAMTS-7 and ADAMTS-12 degradation of cartilage oligomeric matrix protein by alpha-2-macroglobulin.Osteoarthritis Cartilage 2008; 16(11):1413-1420.
  • [28]Apte SS.A disintegrin-like and metalloprotease (reprolysin-type) with thrombospondin type 1 motif (ADAMTS) superfamily:functions and mechanisms.J Biol Chem 2009; 284(46):31493-31497.
  • [29]Vaisar T,Kassim SY,Gomez IG,Green PS,Hargarten S,Gough PJ,Parks WC,Wilson CL,Raines EW,Heinecke JW.MMP-9 sheds the beta2 integrin subunit (CD 18) from macrophages.Mol Cell Proteomics 2009; 8(5):1044-1060.
  • [30]Li W,Li H,Bocking AD,Challis JR.Tumor necrosis factor stimulates matrix metalloproteinase 9 secretion from cultured human chorionic trophoblast cells through TNF receptor 1 signaling to IKBKB-NFKB and MAPK1/3 pathway.Biol Reprod DOI:10.1095/biolreprod.109.082578.
  • [31]Murthy S,Ryan A,He C,Mallampalli RK,Carter AB.Raclmediated mitochondrial H2O2 generation regulates MMP-9 gene expression in macrophages via inhibition of SP-1 and AP-1.J Biol Chem 2010; 285:25062-25073.
  • [32]Moncada-Pazos A,Obaya AJ,Fraga MF,Viloria CG,Capella G,Gausachs M,Esteller M,Lopez-Otin C,Cal S.The ADAMTS12 metalloprotease gene is epigenetically silenced in tumor cells and transcriptionally activated in the stroma during progression of colon cancer.J Cell Sci 2009; 122(Pt 16):2906-2913.
  • [33]Pei D,Weiss SJ.Furin-dependent intracelhlar activation of the human stromelysin-3 zymogen.Nature 1995; 375(6528):244-247.
  • [34]Lohi J,Wilson CL,Roby JD,Parks WC.Epilysin,a novel human matrix metalloproteinase (MMP-28) expressed in testis and keratinocytes and in response to injury.J Biol Chem 2001; 276(13):10134-10144.
  • [35]Lijnen HR.Plasmin and matrix metalloproteinases in vascular remodeling.Thromb Haemost 2001; 86(1):324-333.
  • [36]Sottrup-Jensen L.Alpha-macroglobulins:structure,shape,and mechanism of proteinase complex formation.J Biol Chem 1989; 264(20):11539-11542.
  • [37]Liu CJ.The role of ADAMTS-7 and ADAMTS-12 in the pathogenesis of arthritis.Nat Clin Pratt Rheumatol 2009; 5(1):38-45.
  • [38]Tuuttila A,Morgunova E,Bergmann U,Lindqvist Y,Maskos K,Fernandez-Catalan C,Bode W,Tryggvason K,Schneider G.Three-dimensional structure of human tissue inhibitor of metalloproteinases-2 at 2.1 A resolution.J Mol Biol 1998; 284 (4):1133-1140.
  • [39]Baker AH,Edwards DR,Murphy G.Metalloproteinase inhibitors:biological actions and therapeutic opportunities.J Cell Sci 2002; 115(Pt 19):3719-3727.
  • [40]Brew K,Dinakarpandian D,Nagase H.Tissue inhibitors of metalloproteinases:evolution,structure and function.Biochim Biophys Acta 2000; 1477(1-2):267-283.
  • [41]Owens GK.Regulation of differentiation of vascular smooth muscle cells.Physiol Rev 1995; 75(3):487-517.
  • [42]Hao H,Gabbiani G,Bochaton-Piallat ML.Arterial smooth muscle cell heterogeneity:implications for atherosclerosis and restenosis development.Anerioscler Thromb Vasc Biol 2003; 23(9):1510-1520.
  • [43]Wang L,Zheng J,Du Y,Huang Y,Li J,Liu B,Liu CJ,Zhu Y,Gao Y,Xu Q,Kong W,Wang X.Cartilage oligomeric matrix protein maintains the contractile phenotype of vascular smooth muscle cells by interacting with α(7)β(1) integrin.Circ Res; 106(3):514-525.
  • [44]Kuno K,Okada Y,Kawashima H,Nakamura H,Miyasaka M,Ohno H,Matsushima K.ADAMTS-1 cleaves a cartilage proteoglycan,aggrecan.FEBS Lett 2000; 478(3):241-245.
  • [45]Rodriguez-Manzaneque JC,Carpizo D,Plaza-Calonge Mdel C,Torres-Collado AX,Thai SN,Simons M,Horowitz A,IruelaArispe ML.Cleavage of syndecan-4 by ADAMTS1 provokes defects in adhesion.Int J Biochem Cell Biol 2009; 41(4):800-810.
  • [46]Esselens C,Malapeira J,Colome N,Casal C,RodriguezManzaneque JC,Canals F,Arribas J.The cleavage of semaphorin 3C induced by ADAMTS1 promotes cell migration.J Biol Chem; 285(4):2463-2473.
  • [47]Wang WM,Lee S,Steiglitz BM,Scott IC,Lebares CC,Allen ML,Brenner MC,Takahara K,Greenspan DS.Transforming growth factor-beta induces secretion of activated ADAMTS-2.A procollagen Ⅲ N-proteinase.J Biol Chem 2003; 278(21):19549-19557.
  • [48]Fernandes RJ,Hirohata S,Engle JM,Colige A,Cohn DH,Eyre DR,Apte SS.Procollagen Ⅱ amino propeptide processing by ADAMTS-3.Insights on dermatosparaxis.J Biol Chem 2001; 276(34):31502-31509.
  • [49]Matthews RT,Gary SC,Zerillo C,Pratta M,Solomon K,Arner EC,Hockfield S.Brain-enriched hyaluronan binding (BEHAB)/ brevican cleavage in a glioma cell line is mediated by a disintegrin and metalloproteinase with thrombospondin motifs (ADAMTS) family member.J Biol Chem 2000; 275(30):22695-22703.
  • [50]Kashiwagi M,Enghild JJ,Gendron C,Hughes C,Caterson B,Itoh Y,Nagase H.Altered proteolytic activities of ADAMTS-4 expressed by C-terminal processing.J Biol Chem 2004; 279(11):10109-10119.
  • [51]Sandy JD,Westling J,Kenagy RD,Iruela-Arispe ML,Verscharen C,Rodriguez-Mazaneque JC,Zimmermann DR,Lemire JM,Fischer JW,Wight TN,Clowes AW.Versican V1 proteolysis in human aorta in vivo occurs at the Glu441-Ala442 bond,a site that is cleaved by recombinant ADAMTS-1 and ADAMTS-4.J Biol Chem 2001; 276(16):13372-13378.
  • [52]Sugimoto K,Takahashi M,Yamamoto Y,Shimada K,Tanzawa K.Identification of aggrecanase activity in medium of cartilage culture.J Biochem 1999; 126(2):449-455.
  • [53]Collins-Racie LA,Flannery CR,Zeng W,Corcoran C,AnnisFreeman B,Agostino MJ,Arai M,DiBlasio-Smith E,Dorner AJ,Georgiadis KE,Jin M,Tan XY,Morris EA,LaVallie ER.ADAMTS-8 exhibits aggrecanase activity and is expressed in human articular cartilage.Matrix Biol 2004; 23(4):219-230.
  • [54]Somerville RP,Longpre JM,Jungers KA,Engle JM,Ross M,Evanko S,Wight TN,Leduc R,Apte SS.Characterization of ADAMTS-9 and ADAMTS-20 as a distinct ADAMTS subfamily related to Caenorhabditis elegans GON-1.J Biol Chem 2003; 278(11):9503-9513.
  • [55]Llamazares M,Obaya AJ,Moncada-Pazos A,Heljasvaara R,Espada J,Lopez-Otin C,Cal S.The ADAMTS 12 metalloproteinase exhibits anti-tumorigenic properties through modulation of the Ras-dependent ERK signalling pathway.J Cell Sci 2007; 120(Pt 20):3544-3552.
  • [56]Liu CJ,Kong W,Xu K,Luan Y,Ilalov K,Sehgal B,Yu S,Howell RD,Di Cesare PE.ADAMTS-12 associates with and degrades cartilage oligomeric matrix protein.J Biol Chem 2006; 281(23):15800-15808.
  • [57]Zheng X,Nishio K,Majerus EM,Sadler JE.Cleavage of yon Willebrand factor requires the spacer domain of the metalloprotease ADAMTS13.J Biol Chem 2003; 278(32):30136-30141.
  • [58]Colige A,Beschin A,Samyn B,Goebels Y,Van Beeumen J,Nusgens BV,Lapiere CM.Characterization and partial amino acid sequencing of a 107-kDa procollagen I N-proteinase purified by affinity chromatography on immobilized type XIV collagen.J Biol Chem 1995; 270(28):16724-16730.
  • [59]Colige A,Li SW,Sieron AL,Nusgens BV,Prockop DJ,Lapiere CM.cDNA cloning and expression of bovine procollagen I N-proteinase:a new member of the superfamily of zincmetalloproteinases with binding sites for cells and other matrix components.Proc Nail Acad Sci U S A 1997; 94(6):2374-2379.
  • [60]Gao G,Westling J,Thompson VP,Howell TD,Gottschall PE,Sandy JD.Activation of the proteolytic activity of ADAMTS4 (aggrecanase-1) by C-terminal truncation.J Biol Chem 2002; 277(13):11034-11041.
  • [61]Gao S,De Geyter C,Kossowska K,Zhang H.FSH stimulates the expression of the ADAMTS-16 protease in mature human ovarian follicles.Mol Hum Reprod 2007; 13(7):465-471.
WanfangData CO.,Ltd All Rights Reserved
About WanfangData | Contact US
Healthcare Department, Fuxing Road NO.15, Haidian District Beijing, 100038 P.R.China
Tel:+86-010-58882616 Fax:+86-010-58882615 Email:yiyao@wanfangdata.com.cn